We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App





Sysmex Middle East Presents Smart Lab Technologies at WHX Labs Dubai

By LabMedica International staff writers
Posted on 10 Feb 2026

Sysmex Middle East (Dubai, UAE) is participating in WHX Labs Dubai 2026 as the event’s Smart Lab Partner, showcasing its latest innovations and technologies across a wide range of clinical laboratory disciplines, alongside an educational workshop program. More...

At the company’s stand, key highlights include the UN-Series, a modular urinalysis solution that enables laboratories to automate the urinalysis work area according to their specific workflow requirements. With mix-and-match components, the system can be configured as a fully integrated, scalable solution that supports both current operations and future growth, offering a precise fit and long-term investment security.

Sysmex is also presenting its HISCL series of fully automated, random-access, high-sensitivity immunoassay analyzers designed to deliver rapid and precise clinical diagnostics. The company is emphasizing specialized applications such as liver disease and dementia, highlighting how highly sensitive platforms like the HISCL immunoassay analyzer enable blood-based measurement of Alzheimer’s disease biomarkers, including the β-amyloid 1-42/1-40 ratio.

In hemostasis, the CN-Series, including models such as the CN-3500 and CN-6500, is being highlighted, offering powerful productivity, analytical precision, and operational efficiency based on the “four powers” concept. In hematology, the XR-Series flagship portfolio is on display, providing flexible solutions ranging from standalone analyzers to fully automated systems that can be tailored to varying levels of workflow automation, diagnostic support, and service integration.

Additional exhibits include the company’s modular flow cytometry solutions, encompassing workflow management, automated sample preparation, and a comprehensive range of high-quality antibody reagents.

In parallel with its product showcase, Sysmex is hosting a workshop titled “Smartly linked haemato-oncology: Excellence in every drop” on February 12. The three-part educational session, led by an expert panel, will explore the intersection of laboratory innovation and health system transformation in the diagnosis and management of hematological malignancies.

Related Links:
Sysmex Middle East


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Electrolyte Analyzer
BKE-B
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A simple daily blood test could help critically ill sepsis patients stop antibiotics sooner, reducing overuse and potentially helping combat antibiotic resistance (Image Credit: Adobe Stock)

Daily Blood Biomarker Testing May Help Guide Earlier Antibiotic Stopping in Sepsis

Sepsis is a life-threatening condition caused by the body’s overwhelming response to infection and accounts for thousands of deaths each year. In intensive care, concern about stopping treatment too early... Read more

Immunology

view channel
Image Credit: iStock

Antibody Profiling Predicts Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, involves abnormal immune responses that cause persistent inflammation and damage in the digestive system.... Read more

Pathology

view channel
Image Credit: iStock

AI Tissue Analysis May Help Identify Missed Precancerous Colon Polyps

Colorectal cancer is diagnosed in an estimated 1.9 million people worldwide each year, often without symptoms in its early stages. Timely detection of precancerous lesions is therefore important, yet some... Read more

Technology

view channel
Image: Signals LabGistics uses AI to turn natural-language instructions and SOPs into coordinated scientific workflows, helping connect teams, systems, and processes. (Photo courtesy of Revvity)

New AI-Powered System Aims to Streamline Laboratory and Manufacturing Workflows

Scientific laboratories supporting drug development, biotechnology, and materials research increasingly rely on coordinated digital workflows to move data, samples, and activities across teams.... Read more

Industry

view channel
Image: Beginning in 2027, Quest will provide access to the Onclarity Self-Collection Kit through clinician, health plan, and consumer-initiated testing channels, along with its patient service center network.

Collaboration to Expand Cervical Cancer Screening Access With At-Home HPV Collection

Cervical cancer is largely preventable with regular screening and early detection of human papillomavirus (HPV), the leading cause of the disease. Screening gaps persist, in part because traditional sample... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.